Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 13 | 2023 | 564 | 1.020 |
Why?
|
| Breast Neoplasms | 18 | 2023 | 3155 | 0.870 |
Why?
|
| Hamartoma Syndrome, Multiple | 2 | 2023 | 11 | 0.800 |
Why?
|
| Ovarian Neoplasms | 7 | 2023 | 795 | 0.760 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2023 | 2465 | 0.760 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2021 | 9 | 0.680 |
Why?
|
| RNA Helicases | 1 | 2021 | 37 | 0.670 |
Why?
|
| Genes, BRCA2 | 13 | 2023 | 162 | 0.660 |
Why?
|
| Disease | 1 | 2020 | 91 | 0.610 |
Why?
|
| Genes, BRCA1 | 11 | 2012 | 191 | 0.570 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 202 | 0.560 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 441 | 0.550 |
Why?
|
| Genetic Counseling | 5 | 2021 | 100 | 0.470 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1231 | 0.450 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2020 | 2484 | 0.380 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1763 | 0.370 |
Why?
|
| Community Participation | 1 | 2012 | 39 | 0.370 |
Why?
|
| Awareness | 1 | 2012 | 89 | 0.360 |
Why?
|
| Mutation | 11 | 2021 | 4265 | 0.330 |
Why?
|
| Germ-Line Mutation | 4 | 2022 | 381 | 0.250 |
Why?
|
| BRCA1 Protein | 3 | 2023 | 215 | 0.230 |
Why?
|
| Risk Assessment | 5 | 2021 | 2434 | 0.220 |
Why?
|
| Genetic Carrier Screening | 2 | 2008 | 58 | 0.200 |
Why?
|
| BRCA2 Protein | 2 | 2014 | 173 | 0.190 |
Why?
|
| Female | 24 | 2023 | 48542 | 0.190 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2023 | 147 | 0.190 |
Why?
|
| Humans | 29 | 2023 | 93132 | 0.170 |
Why?
|
| Genital Neoplasms, Female | 1 | 2023 | 113 | 0.170 |
Why?
|
| Hereditary Breast and Ovarian Cancer Syndrome | 1 | 2021 | 12 | 0.170 |
Why?
|
| Counselors | 1 | 2021 | 7 | 0.170 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 131 | 0.160 |
Why?
|
| Health Equity | 1 | 2023 | 101 | 0.160 |
Why?
|
| Mammography | 2 | 2006 | 494 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 647 | 0.150 |
Why?
|
| Complementary Therapies | 1 | 2020 | 53 | 0.150 |
Why?
|
| Breast Neoplasms, Male | 2 | 2014 | 31 | 0.140 |
Why?
|
| Risk Factors | 5 | 2021 | 5900 | 0.130 |
Why?
|
| Middle Aged | 14 | 2023 | 27535 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 298 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 714 | 0.120 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 504 | 0.120 |
Why?
|
| Phenotype | 1 | 2023 | 2545 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 1269 | 0.120 |
Why?
|
| Ovariectomy | 3 | 2009 | 91 | 0.100 |
Why?
|
| Aged | 9 | 2021 | 20395 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 1054 | 0.090 |
Why?
|
| Parent-Child Relations | 2 | 2009 | 80 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2022 | 10128 | 0.080 |
Why?
|
| Adult | 14 | 2021 | 27849 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 740 | 0.070 |
Why?
|
| Heterozygote | 2 | 2008 | 381 | 0.070 |
Why?
|
| Adult Children | 1 | 2009 | 13 | 0.070 |
Why?
|
| Systems Integration | 1 | 2008 | 33 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 2009 | 73 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2008 | 44 | 0.070 |
Why?
|
| Infertility | 1 | 2008 | 34 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 125 | 0.070 |
Why?
|
| Fallopian Tubes | 1 | 2008 | 48 | 0.070 |
Why?
|
| Health Behavior | 3 | 2020 | 182 | 0.070 |
Why?
|
| Bilirubin | 1 | 2007 | 133 | 0.060 |
Why?
|
| Disclosure | 1 | 2007 | 95 | 0.060 |
Why?
|
| Preimplantation Diagnosis | 1 | 2006 | 6 | 0.060 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2006 | 18 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2006 | 83 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2007 | 178 | 0.060 |
Why?
|
| Mastectomy | 1 | 2008 | 262 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2006 | 224 | 0.060 |
Why?
|
| Prevalence | 2 | 2023 | 1318 | 0.060 |
Why?
|
| Computational Biology | 1 | 2008 | 581 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 826 | 0.050 |
Why?
|
| Male | 7 | 2021 | 44355 | 0.050 |
Why?
|
| Disease Progression | 1 | 2006 | 1529 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2014 | 3044 | 0.050 |
Why?
|
| Europe | 1 | 2023 | 338 | 0.040 |
Why?
|
| Ohio | 1 | 2021 | 42 | 0.040 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2021 | 29 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 42 | 0.040 |
Why?
|
| ROC Curve | 1 | 2002 | 774 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2006 | 808 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 7039 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 1519 | 0.040 |
Why?
|
| Pedigree | 3 | 2008 | 962 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2002 | 1120 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2021 | 4546 | 0.030 |
Why?
|
| Diet | 1 | 2020 | 461 | 0.030 |
Why?
|
| Exercise | 1 | 2020 | 353 | 0.030 |
Why?
|
| Data Collection | 2 | 2008 | 370 | 0.030 |
Why?
|
| Adolescent | 4 | 2009 | 9550 | 0.030 |
Why?
|
| Family Health | 2 | 2009 | 154 | 0.030 |
Why?
|
| Neoplasms | 2 | 2008 | 3168 | 0.030 |
Why?
|
| Algorithms | 1 | 2002 | 1948 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group N Protein | 1 | 2014 | 18 | 0.030 |
Why?
|
| Chicago | 2 | 2009 | 1452 | 0.020 |
Why?
|
| Probability | 2 | 2005 | 352 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2014 | 266 | 0.020 |
Why?
|
| Young Adult | 2 | 2020 | 6922 | 0.020 |
Why?
|
| Online Systems | 1 | 2008 | 19 | 0.020 |
Why?
|
| Fertility Agents, Female | 1 | 2008 | 3 | 0.020 |
Why?
|
| Bromocriptine | 1 | 2008 | 12 | 0.020 |
Why?
|
| Menotropins | 1 | 2008 | 20 | 0.020 |
Why?
|
| Clomiphene | 1 | 2008 | 17 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2008 | 67 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 170 | 0.020 |
Why?
|
| Minority Groups | 1 | 2009 | 149 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 100 | 0.020 |
Why?
|
| Dinucleotide Repeats | 1 | 2007 | 14 | 0.020 |
Why?
|
| Estrogens | 1 | 2008 | 194 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2008 | 188 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2008 | 359 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2006 | 36 | 0.010 |
Why?
|
| Public Policy | 1 | 2006 | 59 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 984 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 478 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2006 | 228 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 432 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2006 | 278 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 700 | 0.010 |
Why?
|
| Haplotypes | 1 | 2007 | 647 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 1004 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 627 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1925 | 0.010 |
Why?
|
| United States | 2 | 2006 | 7581 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 1866 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 1240 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 584 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 578 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2001 | 292 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 3890 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2008 | 2787 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 543 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1909 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 1703 | 0.010 |
Why?
|
| Child | 1 | 2007 | 7273 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 1260 | 0.010 |
Why?
|